Article

Taxifolin suppresses UV-induced skin carcinogenesis by targeting EGFR and PI3K. Cancer Prev Res (Phila)

The Hormel Institute, University of Minnesota, 801 16 Ave NE, Austin, MN 55912. .
Cancer Prevention Research (Impact Factor: 5.27). 07/2012; 5(9):1103-14. DOI: 10.1158/1940-6207.CAPR-11-0397
Source: PubMed

ABSTRACT Skin cancer is one of the most commonly diagnosed cancers in the United States. Taxifolin reportedly exerts multiple biologic effects, but the molecular mechanisms and direct target(s) of taxifolin in skin cancer chemoprevention are still unknown. In silico computer screening and kinase profiling results suggest that the EGF receptor (EGFR), phosphoinositide 3-kinase (PI3K), and Src are potential targets for taxifolin. Pull-down assay results showed that EGFR, PI3K, and Src directly interacted with taxifolin in vitro, whereas taxifolin bound to EGFR and PI3K, but not to Src in cells. ATP competition and in vitro kinase assay data revealed that taxifolin interacted with EGFR and PI3K at the ATP-binding pocket and inhibited their kinase activities. Western blot analysis showed that taxifolin suppressed UVB-induced phosphorylation of EGFR and Akt, and subsequently suppressed their signaling pathways in JB6 P+ mouse skin epidermal cells. Expression levels and promoter activity of COX-2 and prostaglandin E(2) (PGE(2)) generation induced by UVB were also attenuated by taxifolin. The effect of taxifolin on UVB-induced signaling pathways and PGE(2) generation was reduced in EGFR knockout murine embryonic fibroblasts (MEF) compared with EGFR wild-type MEFs. Taxifolin also inhibited EGF-induced cell transformation. Importantly, topical treatment of taxifolin to the dorsal skin significantly suppressed tumor incidence, volume, and multiplicity in a solar UV (SUV)-induced skin carcinogenesis mouse model. Further analysis showed that the taxifolin-treated group had a substantial reduction in SUV-induced phosphorylation of EGFR and Akt in mouse skin. These results suggest that taxifolin exerts chemopreventive activity against UV-induced skin carcinogenesis by targeting EGFR and PI3K. Cancer Prev Res; 5(9); 1103-14. ©2012 AACR.

3 Followers
 · 
292 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Diabetic cardiomyopathy has been increasingly recognized as an important cause of heart failure in diabetic patients. Excessive oxidative stress has been suggested to play a critical role in the development of diabetic cardiomyopathy. The objective of this study was to investigate the potential protective effects and mechanisms of taxifolin on cardiac function of streptozotocin-induced diabetic mice and on hyperglycemia-induced apoptosis of H9c2 cardiac myoblasts. In vivo study revealed that taxifolin improved diastolic dysfunction, ameliorated myocardium structure abnormality, inhibited myocyte apoptosis and enhanced endogenous antioxidant enzymes activities. Interestingly, taxifolin reduced angiotensin II level in myocardium, inhibited NADPH oxidase activity, and increased JAK/STAT3 activation. In vitro investigation demonstrated that taxifolin inhibited 33 mM glucoseinduced H9c2 cells apoptosis by decreasing intracellular ROS level. It also inhibited caspase-3 and caspase-9 activation, restored mitochondrial membrane potential, and regulated the expression of proteins related to the intrinsic pathway of apoptosis, thus inhibiting the release of cytochrome c from mitochondria into the cytoplasm. In conclusion, taxifolin exerted cardioprotective effects against diabetic cardiomyopathy by inhibiting oxidative stress and cardiac myocyte apoptosis and might be a potential agent in the treatment of diabetic cardiomyopathy.
    Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association 11/2013; 63. DOI:10.1016/j.fct.2013.11.013 · 2.61 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Targeting specific and multiple cancer genes, signaling proteins, and transcription factors to prevent cancer is now considered to be the most effective means to prevent cancer. Proteins that bind to a specific DNA gene sequence and act to initiate transcription of the distinct protein gene product are referred to as transcription factors. Transcription factors such as activator protein-1 (AP-1), nuclear factor-kappaB (NF-κB), p53, nuclear factor of activated T cells (NFAT), and cAMP response element-binding (CREB) protein have been shown to play a critical role in carcinogenesis and all are regulated by the mitogen-activated protein (MAP) kinase cascades. The activation of these or other transcription factors results in transcription of genes that encode proteins that regulate a multitude of cellular responses including apoptosis, differentiation, development, inflammation, and proliferation. Nutrients and dietary factors have attracted a great deal of interest because of their perceived ability to act as highly effective chemopreventive agents by targeting protein kinases and/or transcription factors, with very few adverse side effects. In the last few years, we have successfully combined computational biology and experimental validation to identify specific molecular targets of a variety of nutrients/phytochemicals, including EGCG, [6]-gingerol, resveratrol, and various flavonoids such as kaempherol, quercetin, and myricetin, to prevent cancer. Understanding the precise molecular mechanisms of these and other nutrients in preventing cancer may reveal key molecular targets for the development of more effective, less toxic anticancer agents ultimately leading to the eradication of cancer as a life-threatening disease. This chapter details the computational methods and software combined with experimental validation methods to successfully identify molecular targets of any phytochemical or nutrient, and also provides citations of examples for the reader’s reference.
    01/2014: pages 1-32;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectives: To investigate the antiplatelet activity of alpha-lipoic acid (α-LA) and dihydroquercetin (DHQ). Materials and Methods: Antiplatelet activity of the α-LA and DHQ was evaluated in rich platelet plasma of rat. The platelet aggregation was induced by adenosine diphosphate (ADP) in concentration of 4 × 10-5 M. Results: α-LA and DHQ inhibited platelet aggregation in concentration-dependent manner. The antiplatelet activity of α-LA was more pronounced than DHQ. DHQ also increased the antiplatelet activity of α-LA by 1.4 times. Conclusion: Combined simultaneous use of α-LA and DHQ possessed the high antiplatelet activity, and DHQ potentiated the activity of α-LA.
    Indian Journal of Pharmacology 07/2014; 46(4):430-2. DOI:10.4103/0253-7613.135958 · 0.68 Impact Factor
Show more